BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 16055375)

  • 21. Magnocellular and parvocellular contributions to backward masking dysfunction in schizophrenia.
    Schechter I; Butler PD; Silipo G; Zemon V; Javitt DC
    Schizophr Res; 2003 Nov; 64(2-3):91-101. PubMed ID: 14613674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early visual sensory deficits as endophenotypes for schizophrenia: high-density electrical mapping in clinically unaffected first-degree relatives.
    Yeap S; Kelly SP; Sehatpour P; Magno E; Javitt DC; Garavan H; Thakore JH; Foxe JJ
    Arch Gen Psychiatry; 2006 Nov; 63(11):1180-8. PubMed ID: 17088498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parvocellular and magnocellular contributions to visual evoked potentials in humans: stimulation with chromatic and achromatic gratings and apparent motion.
    Tobimatsu S; Tomoda H; Kato M
    J Neurol Sci; 1995 Dec; 134(1-2):73-82. PubMed ID: 8747847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Auditory processing in schizophrenia during the middle latency period (10-50 ms): high-density electrical mapping and source analysis reveal subcortical antecedents to early cortical deficits.
    Leavitt VM; Molholm S; Ritter W; Shpaner M; Foxe JJ
    J Psychiatry Neurosci; 2007 Sep; 32(5):339-53. PubMed ID: 17823650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early and late stages of visual processing in individuals in prodromal state and first episode schizophrenia: an ERP study.
    Oribe N; Hirano Y; Kanba S; del Re EC; Seidman LJ; Mesholam-Gately R; Spencer KM; McCarley RW; Niznikiewicz MA
    Schizophr Res; 2013 May; 146(1-3):95-102. PubMed ID: 23433503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The P1 visual-evoked potential, red light, and transdiagnostic psychiatric symptoms.
    Bedwell JS; Spencer CC; Chan CC; Butler PD; Sehatpour P; Schmidt J
    Brain Res; 2018 May; 1687():144-154. PubMed ID: 29510142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Objective assessment of chromatic and achromatic pattern adaptation reveals the temporal response properties of different visual pathways.
    Robson AG; Kulikowski JJ
    Vis Neurosci; 2012 Nov; 29(6):301-13. PubMed ID: 23206417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early visual processing deficits in schizophrenia: impaired P1 generation revealed by high-density electrical mapping.
    Foxe JJ; Doniger GM; Javitt DC
    Neuroreport; 2001 Dec; 12(17):3815-20. PubMed ID: 11726801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visual evoked spread spectrum analysis (VESPA) responses to stimuli biased towards magnocellular and parvocellular pathways.
    Lalor EC; Foxe JJ
    Vision Res; 2009 Jan; 49(1):127-33. PubMed ID: 18977382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vision abnormalities in young children exposed prenatally to organic solvents.
    Till C; Westall CA; Koren G; Nulman I; Rovet JF
    Neurotoxicology; 2005 Aug; 26(4):599-613. PubMed ID: 16054697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transdiagnostic psychiatric symptoms related to visual evoked potential abnormalities.
    Bedwell JS; Butler PD; Chan CC; Trachik BJ
    Psychiatry Res; 2015 Dec; 230(2):262-70. PubMed ID: 26412383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consequences of magnocellular dysfunction on processing attended information in schizophrenia.
    Martínez A; Hillyard SA; Bickel S; Dias EC; Butler PD; Javitt DC
    Cereb Cortex; 2012 Jun; 22(6):1282-93. PubMed ID: 21840846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How does the hippocampal formation mediate memory for stimuli processed by the magnocellular and parvocellular visual pathways? Evidence from the comparison of schizophrenia and amnestic mild cognitive impairment (aMCI).
    Kéri S; Szamosi A; Benedek G; Kelemen O
    Neuropsychologia; 2012 Dec; 50(14):3193-9. PubMed ID: 23085125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contrast response properties of magnocellular and parvocellular pathways in retinitis pigmentosa assessed by the visual evoked potential.
    Alexander KR; Rajagopalan AS; Seiple W; Zemon VM; Fishman GA
    Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2967-73. PubMed ID: 16043873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elementary sensory deficits in schizophrenia indexed by impaired visual mismatch negativity.
    Farkas K; Stefanics G; Marosi C; Csukly G
    Schizophr Res; 2015 Aug; 166(1-3):164-70. PubMed ID: 26072712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the functions of the parvocellular and magnocellular pathways in strabismic amblyopia.
    Demirci H; Gezer A; Sezen F; Ovali T; Demiralp T; Isoglu-Alkoc U
    J Pediatr Ophthalmol Strabismus; 2002; 39(4):215-21. PubMed ID: 12148554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defective chromatic and achromatic visual pathways in developmental dyslexia: Cues for an integrated intervention programme.
    Bonfiglio L; Bocci T; Minichilli F; Crecchi A; Barloscio D; Spina DM; Rossi B; Sartucci F
    Restor Neurol Neurosci; 2017; 35(1):11-24. PubMed ID: 27858722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Visual emotional information processing in male schizophrenia patients: combining ERP, clinical and behavioral evidence.
    Pinheiro AP; Liu T; Nestor PG; McCarley RW; Gonçalves ÓF; Niznikiewicz MA
    Neurosci Lett; 2013 Aug; 550():75-80. PubMed ID: 23810800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of impaired early-stage visual processing to working memory dysfunction in adolescents with schizophrenia: a study with event-related potentials and functional magnetic resonance imaging.
    Haenschel C; Bittner RA; Haertling F; Rotarska-Jagiela A; Maurer K; Singer W; Linden DE
    Arch Gen Psychiatry; 2007 Nov; 64(11):1229-40. PubMed ID: 17984392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of red surrounds on visual magnocellular and parvocellular cortical processing and perception.
    Hugrass L; Verhellen T; Morrall-Earney E; Mallon C; Crewther DP
    J Vis; 2018 Apr; 18(4):8. PubMed ID: 29621385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.